𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of homoharringtonine in patients with recurrent primary malignant central nervous system tumors

✍ Scribed by Lynn G. Feun; Niramol Savaraj; Howard Landy; Howard Levin; Theodore Lampidis


Publisher
Springer US
Year
1990
Tongue
English
Weight
337 KB
Volume
9
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase II evaluation of fludarabine phosp
✍ Sarah A. Taylor; John Crowley; F. Stephen Vogel; Jeannette J. Townsend; Harmon J πŸ“‚ Article πŸ“… 1991 πŸ› Springer US 🌐 English βš– 147 KB

Twenty-three patients with malignant central nervous system tumors were treated with fludarabine phosphate (2-FAMP) on a 5 day bolus schedule. One brief partial response was observed in 20 malignant astrocytoma patients. 2FAMP as given in this protocol is inactive in previously treated patients with

Phase 2 study of temozolomide in childre
✍ H. Stacy Nicholson; Cynthia S. Kretschmar; Mark Krailo; Mark Bernstein; Richard πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Effective chemotherapy is lacking for most types of central nervous system (CNS) tumors in children. Temozolomide, an agent with activity against adult brain tumors, was investigated in children and adolescents with recurrent CNS tumors. ## METHODS. Temozolomide was ad

Hyperthermia for the treatment of patien
✍ RΓΌdiger Wessalowski; Heidi Kruck; Hildegard Pape; Thomas Kahn; Reinhart Willers; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 151 KB πŸ‘ 3 views

waves in combination with platinum-based chemotherapy in ten children and 4 Institute of Statistics, Heinrich-Heine Univeradolescents with recurrent or refractory GCTs. sity, Du Β¨sseldorf, Germany. ## RESULTS. Seven of ten patients with recurrent or refractory GCTs had objective responses. Of the